25.63
1.62 (6.75%)
| Previous Close | 24.01 |
| Open | 24.00 |
| Volume | 1,021,123 |
| Avg. Volume (3M) | 927,647 |
| Market Cap | 1,476,235,136 |
| Price / Book | 1.87 |
| 52 Weeks Range | |
| Earnings Date | 7 Aug 2025 |
| Diluted EPS (TTM) | -2.58 |
| Total Debt/Equity (MRQ) | 0.92% |
| Current Ratio (MRQ) | 23.29 |
| Operating Cash Flow (TTM) | -134.78 M |
| Levered Free Cash Flow (TTM) | -80.30 M |
| Return on Assets (TTM) | -17.24% |
| Return on Equity (TTM) | -22.85% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Structure Therapeutics Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 2.13 |
|
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 3.08% |
| % Held by Institutions | 101.62% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 90.00 (Guggenheim, 251.15%) | Buy |
| Median | 87.00 (239.45%) | |
| Low | 60.00 (HC Wainwright & Co., 134.10%) | Buy |
| Average | 79.00 (208.23%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 16.20 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Guggenheim | 07 Aug 2025 | 90.00 (251.15%) | Buy | 16.20 |
| HC Wainwright & Co. | 07 Aug 2025 | 60.00 (134.10%) | Buy | 16.20 |
| JMP Securities | 07 Aug 2025 | 87.00 (239.45%) | Buy | 16.20 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 02 Sep 2025 | Announcement | Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences |
| 06 Aug 2025 | Announcement | Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |